Emmaus Life Sciences EMMA Stock
Emmaus Life Sciences Price Chart
Emmaus Life Sciences EMMA Financial and Trading Overview
| Emmaus Life Sciences stock price | 0.01 USD |
| Previous Close | 0.01 USD |
| Open | 0.01 USD |
| Bid | 0.0096 USD x 11000000 |
| Ask | 0.01 USD x 3000000 |
| Day's Range | 0.0096 - 0.01 USD |
| 52 Week Range | 0.008 - 0.02 USD |
| Volume | 703.57K USD |
| Avg. Volume | 49.45K USD |
| Market Cap | 808.57K USD |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.13 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
EMMA Valuation Measures
| Enterprise Value | N/A |
| Trailing P/E | N/A |
| Forward P/E | -0.16457143 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Emmaus Life Sciences Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | -27.18% |
| S&P500 52-Week Change | 27.29% |
| 52 Week High | 0.02 USD |
| 52 Week Low | 0.008 USD |
| 50-Day Moving Average | 0.01 USD |
| 200-Day Moving Average | 0.01 USD |
EMMA Share Statistics
| Avg. Volume (3 month) | 49.45K USD |
| Avg. Daily Volume (10-Days) | 121.02K USD |
| Shares Outstanding | 70.19M |
| Float | N/A |
| Short Ratio | 0.48 |
| % Held by Insiders | 47.07% |
| % Held by Institutions | 0% |
| Shares Short | 41.22K |
| Short % of Float | 0.090% |
| Short % of Shares Outstanding | 0.090% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:6 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | March 31, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | N/A |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | 0.19 USD |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | N/A |
| Diluted EPS (ttm) | -0.13 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | N/A |
| Total Cash Per Share (mrq) | N/A |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | N/A |
| Book Value Per Share (mrq) | -0.906 |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Profile of Emmaus Life Sciences
| Country | United States |
| State | CA |
| City | Torrance |
| Address | 21250 Hawthorne Boulevard |
| ZIP | 90503 |
| Phone | 310 214 0065 |
| Website | https://www.emmausmedical.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 32 |
Emmaus Life Sciences, Inc., a commercial-stage biopharmaceutical company, discovers, develops, markets, and sells treatments and therapies primarily for rare and orphan diseases in the United States and internationally. The company's lead candidate is Endari, an L-glutamine oral powder to reduce the acute complications of sickle cell disease (SCD) in adult and pediatric patients five years of age and older. It has a license agreement with Kainos Medicine, Inc., which includes the patent rights of IRAK4 inhibitor, referred to as KM10544, for the treatment of cancers, such as leukemia, lymphoma, and solid tumor cancers. Emmaus Life Sciences, Inc. was founded in 2000 and is headquartered in Torrance, California.
Q&A For Emmaus Life Sciences Stock
What is a current EMMA stock price?
Emmaus Life Sciences EMMA stock price today per share is 0.01 USD.
How to purchase Emmaus Life Sciences stock?
You can buy EMMA shares on the OTC Markets OTCQB exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Emmaus Life Sciences?
The stock symbol or ticker of Emmaus Life Sciences is EMMA.
Which industry does the Emmaus Life Sciences company belong to?
The Emmaus Life Sciences industry is Biotechnology.
How many shares does Emmaus Life Sciences have in circulation?
The max supply of Emmaus Life Sciences shares is 69.88M.
What is Emmaus Life Sciences Price to Earnings Ratio (PE Ratio)?
Emmaus Life Sciences PE Ratio is now.
What was Emmaus Life Sciences earnings per share over the trailing 12 months (TTM)?
Emmaus Life Sciences EPS is -0.13 USD over the trailing 12 months.
Which sector does the Emmaus Life Sciences company belong to?
The Emmaus Life Sciences sector is Healthcare.